# Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)

> **NCT02303587** · NA · COMPLETED · sponsor: **Beijing Children's Hospital** · enrollment: 424 (actual)

## Conditions studied

- Mycoplasma Pneumoniae Pneumonia

## Interventions

- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT02303587
- **Lead sponsor:** Beijing Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2019-10-16
- **Final completion:** 2019-10-16
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2021-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02303587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02303587, "Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02303587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*